Understanding Metabolic Changes During the Transition From Weight Loss Medications The human body undergoes significant adaptations during pharmacologic weight loss
What Our Patients Say The monthly follow-ups and lab monitoring gave me confidence that I was losing weight safely
Keep the needle under the skin and count slowly to six before removing it
[PMID: 19467220] PubMed record related to this compound for laboratory literature review
Become a member or renew your membership today
The GLP-1 medications currently approved and used in clinical practice, primarily for the treatment of type 2 diabetes and obesity, include: Semaglutide: Ozempic, Wegovy, Rybelsus Tirzepatide: Mounjaro, Zepbound Liraglutide: Victoza, Saxenda Dulaglutide: Trulicity Exenatide: Byetta, Bydureon Expanding Beyond Obesity The therapeutic potential of GLP-1s extends beyond weight management